Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14276 - 14300 of 14745 in total

Dexpramipexole

Dexpramipexole is under investigation in clinical trial NCT01511029 (Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)).
Investigational
Matched Description: … investigation in clinical trial NCT01511029 (Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With …

5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole

5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. This drug is known to target genome polyprotein.
Experimental
Matched Description: … These are aromatic compounds containing an ether group substituted with a benzene ring. …

N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide

Experimental

4-Acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2H-pyran-2-carboxylic acid

Experimental

N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE

Experimental

(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine

Experimental

N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide

Experimental

N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE

Experimental

5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID

Experimental

Carmegliptin

Carmegliptin has been used in trials studying the treatment of Diabetes Mellitus Type 2.
Investigational

5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione

Experimental

(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID

Experimental

2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL

Experimental

BMS-903452

BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational

Imiglitazar

Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.
Investigational

E-6005

E6005 has been used in trials studying the treatment of Atopic Dermatitis.
Investigational

MRX-I

MRX-I has been used in trials studying the treatment of Bacterial Infections.
Investigational

4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE

Experimental

2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide

Experimental

2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE

Experimental

Lortalamine

Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. This drug never made it past clinical trials, likely due to ocular toxicity in animals, but has been used in positron emission tomography studies to label norepinephrine transporters.
Experimental

T-62

T-62 has been used in trials studying the treatment of Postherpetic Neuralgia.
Investigational

Roluperidone

Roluperidone has been used in trials studying the treatment of Schizophrenia.
Investigational

Norclobazam

Investigational

Sirpiglenastat

Sirpiglenastat, also known as DRP-104, is a prodrug of 6-diazo-5-oxo-L-norleucine (DON), which is a broad-acting glutamine antagonist. It is under investigation in clinical trial NCT04471415 (Study to Investigate DRP-104 in Adults With Advanced Solid Tumors).
Investigational
Matched Description: … It is under investigation in clinical trial NCT04471415 (Study to Investigate DRP-104 in Adults With …
Displaying drugs 14276 - 14300 of 14745 in total